Picture of LumiraDx logo

LMDXF — LumiraDx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Lumiradx Reports Fourth Quarter And Full Year 2022 Results

March 21 (Reuters) - Lumiradx Ltd  LMDX.O :
    * LUMIRADX REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS
    * QTRLY LOSS PER SHARE $0.32
    * RECORDED AN ACCOUNTING IMPAIRMENT OF $96 MILLION IN Q4 OF
2022
FOR EXCESS MANUFACTURING AND INVENTORY RELATED TO AMIRA COVID
TESTS
    * Q4 2022 REVENUE OF $41.1 MILLION COMPARED TO Q4 2021
REVENUE OF
$118.3 MILLION
    * Q4 EARNINGS PER SHARE VIEW $-0.20, REVENUE VIEW $41.7
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7sWQ9f 
Further company coverage:  LMDX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on LumiraDx

See all news